Results 151 to 152 of about 14,165 (152)

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

Journal of Clinical Oncology
Dennis J Slamon, Hope S Rugo, Nadia Harbeck   +2 more
exaly  

Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study

Lancet Oncology, The
exaly